生化汤和米非司酮联合利凡诺用于中期引产的临床观察  

Clinical Observation of ShengHua Tang and Mifepristone in Combination with Rivanol on Induction of Labor in Mid-pregnancy

作　　者：王海锋[1] 刘青[1] 

机构地区：[1]秦皇岛市第二医院,河北秦皇岛066600

出　　处：《西部中医药》2016年第12期89-90,共2页Western Journal of Traditional Chinese Medicine

摘　　要：目的:观察生化汤及米非司酮联合利凡诺用于中期引产的临床疗效。方法:将120例患者按照随机数字表法分为观察组、对照组各60例,对照组采用利凡诺进行中期引产,观察组在对照组治疗的基础上加用生化汤与米非司酮,观察宫缩启动时间、排胎时间、出血量及引产术后并发症发生情况。结果:宫缩启动时间、排胎时间、平均出血量、引产成功率,2组比较差异均有统计学意义(P<0.05)。并发症发生率观察组为20.00%,对照组为98.33%,2组比较差异有统计学意义(P<0.05)。结论:采用生化汤和米非司酮联合利凡诺用于中期引产,可缩短宫缩启动时间、排胎时间,减少出血量,减少并发症。Objective： To observe the clinical effect of ShengHua Tang and mifepristone in combination with rivanol on induction of labor in mid-pregnancy. Methods： According to the digital tabulation method, 120 cases were randomly divided into the observation group and the control group, and 60 cases in each group. The control group was given rivanol for induction of labor in mid-pregnancy, and based on the treatment of the control group, ShengHua Tang and mifepristone were added for the observation group. The time of uterine contractions start, the time of deliv- ery, blood loss and the occurrence of complications after the induction operation were observed. Results： The time of uterine contractions start, the time of delivery, mean blood loss and success rate of abortion of two groups were com- pared, the differences were statistically significant（P〈0.05）. The incidence rate of complications was 20.00% in the observation group and 98.33% in the control group, the difference was statistically significant （P〈0.05）. Conclu- sion： ShengHua Tang and mifepristone in combination with rivanol for the treatment of induction of labor in mid-preg- nancy can shorten uterine contractions start time and delivery time, reduce the blood loss and the occurrence ofcomo plications.

关 键 词：中期引产 生化汤 米非司酮 利凡诺 

分 类 号：R979.2[医药卫生—药品]